$CIEN — AVOID 📊 | 6 MONTHS THESIS

$CIEN — AVOID 📊 | 6 MONTHS THESIS 🎯 FQ2 FY2026 (ends May) | reported Jun 04 | Rev $1.6B | EPS $1.64 vs $1.46 🟢 | Margin 15.1% 💡 Consensus already expected strong results, as shown by the 0th percentile quant rank and extreme relative valuation. The beat does not close the gap between price and intrinsic value; the market may be extrapolating unsustainable growth, while reverse DCF implies -3.6% FCF growth needed to justify current price, indicating downside even on good... 🏢 Business Quality: 8 — leading optical networking player with solid execution, but cyclical and competitive pressures exist/10 📊 Valuation: rich — at 149.2x P/E, 239th percentile historically, with peer range 7.4x-46.2x and median 18.7x. 🔮 Catalyst: Q3 FY26 earnings (expected Sept 2026) ⚖️ Avoid CIEN at $480: extreme overvaluation with 149x P/E offers poor reward/risk; wait for a severe correction before reconsidering.

🎯 FQ2 FY2026 (ends May) | reported Jun 04 | Rev $1.6B | EPS $1.64 vs $1.46 🟢 | Margin 15.1%